Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retraction Notice to "Physcion 8-O-β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells of hepatocellular carcinoma HepG2 cells" [Biomedicine & Pharmacotherapy 83 (2016) 372-380].
Wang Q, Wang Y, Xing Y, Yan Y, Guo P, Zhuang J, Qin F, Zhang J. Wang Q, et al. Among authors: guo p. Biomed Pharmacother. 2021 Jan;133:110882. doi: 10.1016/j.biopha.2020.110882. Epub 2020 Nov 26. Biomed Pharmacother. 2021. PMID: 33249279 Free article. No abstract available.
Chrysophanol exhibits anti-cancer activities in lung cancer cell through regulating ROS/HIF-1a/VEGF signaling pathway.
Zhang J, Wang Q, Wang Q, Guo P, Wang Y, Xing Y, Zhang M, Liu F, Zeng Q. Zhang J, et al. Among authors: guo p. Naunyn Schmiedebergs Arch Pharmacol. 2020 Mar;393(3):469-480. doi: 10.1007/s00210-019-01746-8. Epub 2019 Oct 26. Naunyn Schmiedebergs Arch Pharmacol. 2020. Retraction in: Naunyn Schmiedebergs Arch Pharmacol. 2021 Mar;394(3):577-578. doi: 10.1007/s00210-020-02019-5. PMID: 31655854 Retracted.
RETRACTED: Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis.
Wang Q, Yan Y, Zhang J, Guo P, Xing Y, Wang Y, Qin F, Zeng Q. Wang Q, et al. Among authors: guo p. Biomed Pharmacother. 2018 Aug;104:28-35. doi: 10.1016/j.biopha.2018.05.013. Epub 2018 May 11. Biomed Pharmacother. 2018. Retraction in: Biomed Pharmacother. 2021 Feb;134:111070. doi: 10.1016/j.biopha.2020.111070. PMID: 29758413 Retracted.
RETRACTED: Physcion 8-O-β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells.
Wang Q, Wang Y, Xing Y, Yan Y, Guo P, Zhuang J, Qin F, Zhang J. Wang Q, et al. Among authors: guo p. Biomed Pharmacother. 2016 Oct;83:372-380. doi: 10.1016/j.biopha.2016.06.045. Epub 2016 Jul 14. Biomed Pharmacother. 2016. Retraction in: Biomed Pharmacother. 2021 Jan;133:110882. doi: 10.1016/j.biopha.2020.110882. PMID: 27416558 Retracted.
Retraction notice to "physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis" [Biomed. Pharmacother. 104 (2018) 28-35].
Wang Q, Yi Y, Zhang J, Guo P, Xing Y, Wang Y, Qin F, Zeng Q. Wang Q, et al. Among authors: guo p. Biomed Pharmacother. 2021 Feb;134:111070. doi: 10.1016/j.biopha.2020.111070. Epub 2020 Dec 28. Biomed Pharmacother. 2021. PMID: 33383313 Free article. No abstract available.
4,172 results